KALA BIO , Inc. (NASDAQ: KALA) (“KALA BIO” or the “Company”), today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the “common stock”) at a ...

ESTERO, FL / ACCESS Newswire / May 7, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), ...

CONROE, TX / ACCESS Newswire / May 6, 2026 / Olenox Industries Inc. (NASDAQ:OLOX) ("Olenox" or the "Company"), a ...

Discover how the Gordon Growth Model calculates stock value using constant dividend growth, including key inputs and examples ...

This clinical-stage biotech focused on CNS disorders reported a notable insider sale, as disclosed in its latest SEC filing.

OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Financial Inc. (NYSE: EFC) ("we") today announced an estimated book value per share of common stock of $13.31 as of January 31, 2026. This estimate ...